Nanjing King-Friend Biochemical Pharmaceutical Co (SHSE:603707) Other Long Term Assets : ¥336 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Nanjing King-Friend Biochemical Pharmaceutical Co Other Long Term Assets?

Nanjing King-Friend Biochemical Pharmaceutical Co's other long-term assets for the quarter that ended in Mar. 2025 was ¥336 Mil.

Nanjing King-Friend Biochemical Pharmaceutical Co's quarterly other long-term assets declined from Sep. 2024 (¥555 Mil) to Dec. 2024 (¥341 Mil) but then stayed the same from Dec. 2024 (¥341 Mil) to Mar. 2025 (¥336 Mil).

Nanjing King-Friend Biochemical Pharmaceutical Co's annual other long-term assets increased from Dec. 2022 (¥181 Mil) to Dec. 2023 (¥432 Mil) but then declined from Dec. 2023 (¥432 Mil) to Dec. 2024 (¥341 Mil).

Nanjing King-Friend Biochemical Pharmaceutical Co Other Long Term Assets Historical Data

The historical data trend for Nanjing King-Friend Biochemical Pharmaceutical Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing King-Friend Biochemical Pharmaceutical Co Other Long Term Assets Chart

Nanjing King-Friend Biochemical Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

142.76

144.84

180.77

432.46

341.22

Nanjing King-Friend Biochemical Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long Term Assets	Get a 7-Day Free Trial															430.75	642.25	555.42	341.22	336.22

Nanjing King-Friend Biochemical Pharmaceutical Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Nanjing King-Friend Biochemical Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) » Definitions » Other Long Term Assets

Traded in Other Exchanges

N/A

Address

1/16 Xuefu Road, Nanjing High-Tech Zone, Nanjing, CHN, 210061

Website

http://www.nkf-pharma.com

Nanjing King-Friend Biochemical Pharmaceutical Co Ltd is a China-based company engaged in the research and development, import and export of medicines and health products. The main products of the company are Heparin sodium and low molecular weight heparin. Geographically, the business activities are carried out through China and it exports the product mainly to the European and American countries.

Executives

Huang Xi Wei	Director
Liu Zu Qing	Supervisors
Xie Ju Hua	Director
Wu Gui Ping	senior management
Tang Yong Qun	Director
Qian Xiao Jie	senior management

Nanjing King-Friend Biochemical Pharmaceutical Co Headlines

No Headlines